No Data
No Data
No Data
No Data
No Data
三愛健康集團:二零二三年年報
Futu NewsApr 25 19:27 · Announcements
Sanai Health Group (01889.HK) issued a total of 612 million new shares due to the exchange of convertible stock notes
Sanai Health Group (01889.HK) issued an announcement to issue and distribute 349 million new shares on April 23, 2024 in exchange for convertible notes due 2026 with a principal amount of HK$34.2 million based on an adjusted conversion price of HK$0.098 per share.
Zhitong FinanceApr 24 06:53
Sanai Health Unit to Offload 59% Stake in Genetic Testing Provider
Sanai Health Industry Group (HKG:1889) unit Sanai International Investment will sell its 59% equity interest in Zentrogene Bioscience Laboratory to Merit Investment Holding for HK$22 million, accordin
MT NewswiresApr 18 17:43
Sanai Health Group (01889) plans to sell 59% of Zentrogene Bioscience Laboratory Limited's shares for HK$22 million
Sanai Health Group (01889) announced that on April 17, 2024, the company is a wholly-owned subsidiary of Sanai International Investment...
Zhitong FinanceApr 17 22:18
Sanai Health Group (01889) announced annual results. Profit attributable to shareholders was 18.633 million yuan, a year-on-year decrease of 36.23%
According to the Zhitong Finance App, Sanai Health Group (01889) announced its 2023 annual results, with revenue of about 122 million yuan (RMB, same below); a year-on-year decrease of about 30.59%; profit attributable to company owners was 18.633 million yuan, a year-on-year decrease of 36.23%; profit per share was 0.58 points. According to reports, the decline in earnings was mainly due to a decrease in sales of self-produced pharmaceutical products and sales of pharmaceutical products from other non-competitive pharmaceutical companies.
Zhitong FinanceMar 28 06:15
SANAI HEALTH GP: ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED 31 DECEMBER 2023
Futu NewsMar 28 06:04 · Announcements
No Data
No Data